4D Pharma PLC LBPS:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/12/21 EDT
12.73quote price arrow down-0.52 (-3.92%)
Volume
6,968
52 week range
11.56 - 15.50

...

Loading . . .
  • Open12.57
  • Day High12.98
  • Day Low12.48
  • Prev Close12.73
  • 52 Week High15.50
  • 52 Week High Date03/22/21
  • 52 Week Low11.56
  • 52 Week Low Date03/30/21

Key Stats

  • Market Cap214.18M
  • Shares Out131.47M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open12.57
  • Day High12.98
  • Day Low12.48
  • Prev Close12.73
  • 52 Week High15.50
  • 52 Week High Date03/22/21
  • 52 Week Low11.56
  • 52 Week Low Date03/30/21
  • Market Cap214.18M
  • Shares Out131.47M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From 4D Pharma PLC

There is no recent news for this security.

Profile

MORE
4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved...
Axel Glasmacher M.D.
Non-Executive Chairman
Duncan Peyton
Chief Executive Officer
John Beck Sr., CPA
Chief Financial Officer
Address
9 Bond Court
Leeds
LS1 2JZ
United Kingdom